Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension
An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with car...
Saved in:
Published in | Journal of human hypertension Vol. 30; no. 7; pp. 424 - 429 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.07.2016
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0950-9240 1476-5527 1476-5527 |
DOI | 10.1038/jhh.2015.59 |
Cover
Loading…
Abstract | An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima–media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT. |
---|---|
AbstractList | An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT. An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT. Journal of Human Hypertension (2016) 30, 424-429; doi: 10.1038/jhh.2015.59; published online 4 June 2015 An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT.An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was to examine the distribution of the serum procalcitonin (PCT), pentraxin (PTX)-3 and interleukin (IL)-33 levels and their relationship with carotid intima-media thickness (CIMT) in subjects with white coat HT (WCH), HT and normotension (NT) groups. Thirty-three patients with HT, 33 patients with WCH and 33 healthy subjects were enrolled in this study. PCT, PTX-3 and C-reactive protein (CRP) levels significantly increased in the HT group compared with the NT group. In addition, PCT and CRP levels were significantly higher in the WCH group than in the NT group. CIMT measurements were significantly higher in the WCH and HT groups than in the NT group. In the HT and WCH groups, there were significant positive correlations between PTX-3, PCT and CRP. In the WCH group, PTX-3 and PCT levels were significantly positively correlated with CIMT. PCT had area under the curve value of 0.817 which demonstrates its sufficiency to distinguish WCH from NT individuals. Our results suggest that in subjects with WCH and HT, which are characterized by increased cardiovascular risk, PTX-3 and PCT levels in the HT group and PCT levels in the WCH group are significantly and consistently higher than normotensives. Systemic inflammation moderately occurs in the WCH and HT groups. PCT monitoring may be a useful biomarker in inflammation related to atherosclerosis and early stage HT. |
Audience | Academic |
Author | Yavuzer, S Uzun, H Rıza Altıparmak, M Yaldıran, A L Yavuzer, H Balci, H Korkmazer, B Cengiz, M |
Author_xml | – sequence: 1 givenname: H surname: Yavuzer fullname: Yavuzer, H organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University – sequence: 2 givenname: M surname: Cengiz fullname: Cengiz, M organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University – sequence: 3 givenname: S surname: Yavuzer fullname: Yavuzer, S email: drserapsahin@gmail.com organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University – sequence: 4 givenname: M surname: Rıza Altıparmak fullname: Rıza Altıparmak, M organization: Department of Nephrology, , Cerrahpasa Medical Faculty, Istanbul University – sequence: 5 givenname: B surname: Korkmazer fullname: Korkmazer, B organization: Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University – sequence: 6 givenname: H surname: Balci fullname: Balci, H organization: Central Research Laboratory, Cerrahpasa Medical Faculty, Istanbul University – sequence: 7 givenname: A L surname: Yaldıran fullname: Yaldıran, A L organization: Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University – sequence: 8 givenname: H surname: Uzun fullname: Uzun, H organization: Department of Biochemistry, Cerrahpasa Medical Faculty, Istanbul University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26040439$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9rFDEQx4NU7LX65LssCCLonpNfu4lvx-EvKNgHfRNCNpvt5dxNzmQX7X9v1mvxLIclD8NkPjPJzHzP0IkP3iL0FMMSAxVvtpvNkgDmSy4foAVmdVVyTuoTtADJoZSEwSk6S2kLMAfFI3RKKmDAqFygb5cxGN0bNwbvfKF9W1xaP0b9y_mSvi3WU4zZLxoXBh2_25iKjDnf9XoY9OjC7BQ_N260hQl6LDbXOxtH61MOPUYPO90n--TGnqOv7999WX8sLz5_-LReXZSGMzaWTHZCGNk2pGuFENmwhtS25RRqabNLuaFtRyxpWi06CVJg2lQGrCQUN4aeo5f7ursYfkw2jWpwydi-196GKSksQFSEcKD3o7XkoqpxRTL6_A66DVP0uRFFKgYVBS7_S-VajMncA_ylrnRvVR5fyCM289NqxXgFktWUZ2p5hMqntYMzeeudy_f_JLw4SNhY3Y-bFPpp3ktSq4oD8BrXcB94WPHZTTtTM9hW7aLLe79Wt4rJAN4DJoaUou1U1s4fIeS_ul5hULMqVValmlWp-Jzz6k7Obdnj9Os9nTLlr2w8mOgR_DeJpu0R |
CitedBy_id | crossref_primary_10_1111_jch_13273 crossref_primary_10_14814_phy2_70086 crossref_primary_10_18705_1607_419X_2023_29_2_124_137 crossref_primary_10_1097_HJH_0000000000003073 crossref_primary_10_1515_tjb_2022_0237 crossref_primary_10_1038_s41371_019_0250_7 crossref_primary_10_1111_jch_12882 crossref_primary_10_32322_jhsm_969699 |
Cites_doi | 10.3109/08037051.2012.745226 10.5543/tkda.2013.20025 10.1093/gerona/glq030 10.1111/j.1365-2796.2012.02548.x 10.1161/01.CIR.98.8.731 10.1093/ndt/gfl019 10.1253/circj.CJ-10-0638 10.1097/MBP.0b013e3283651d19 10.1189/jlb.1005557 10.1097/HJH.0b013e328360ddd5 10.1136/bmj.322.7285.531 10.1055/s-0033-1348880 10.1001/jama.2009.943 10.1182/blood-2009-02-203372 10.1001/jama.290.22.2945 10.1084/jem.20071868 10.2337/dc08-s246 10.1016/j.jash.2011.03.004 10.1177/147323001003800106 10.1161/01.CIR.74.6.1399 10.1161/01.HYP.0000146691.51307.84 10.1186/1476-9255-8-22 10.1536/ihj.13-253 10.1097/00004872-200105000-00004 10.1161/ATVBAHA.111.231431 10.1016/S0895-7061(03)00566-1 10.1161/hh2101.099270 10.1136/bmj.320.7242.1128 10.1001/jama.1988.03720020027031 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited 2016 COPYRIGHT 2016 Nature Publishing Group Copyright Nature Publishing Group Jul 2016 Macmillan Publishers Limited 2016. |
Copyright_xml | – notice: Macmillan Publishers Limited 2016 – notice: COPYRIGHT 2016 Nature Publishing Group – notice: Copyright Nature Publishing Group Jul 2016 – notice: Macmillan Publishers Limited 2016. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1038/jhh.2015.59 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic MEDLINE ProQuest Central Student AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1476-5527 |
EndPage | 429 |
ExternalDocumentID | 4081194661 A456094735 A650057170 26040439 10_1038_jhh_2015_59 |
Genre | Journal Article |
GeographicLocations | Turkey |
GeographicLocations_xml | – name: Turkey |
GroupedDBID | --- -Q- 0R~ 29K 2WC 36B 39C 3V. 4.4 406 53G 5GY 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 A8Z AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABAWZ ABCQX ABDBF ABJNI ABLJU ABOCM ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 D-I DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC IWAJR JSO JZLTJ KQ8 L7B M1P M7P NAO NQJWS O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP W2D YYP ZXP ~8M AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB PMFND 7T5 7XB 8FE 8FH 8FK ABRTQ AZQEC DWQXO GNUQQ H94 K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c544t-49f88c9db2fd888b2f4b27ed53079eb2f35c3df2e2bda8f909813b6c0e9231bc3 |
IEDL.DBID | BENPR |
ISSN | 0950-9240 1476-5527 |
IngestDate | Thu Sep 04 22:01:53 EDT 2025 Thu Sep 04 22:57:15 EDT 2025 Sat Aug 23 12:48:06 EDT 2025 Fri Jul 25 09:11:50 EDT 2025 Tue Jun 17 21:35:44 EDT 2025 Tue Jun 10 20:47:09 EDT 2025 Thu May 22 21:32:51 EDT 2025 Thu May 22 21:04:41 EDT 2025 Thu Apr 03 07:05:32 EDT 2025 Thu Apr 24 23:03:12 EDT 2025 Tue Jul 01 03:25:31 EDT 2025 Fri Feb 21 02:39:44 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c544t-49f88c9db2fd888b2f4b27ed53079eb2f35c3df2e2bda8f909813b6c0e9231bc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 26040439 |
PQID | 1794490790 |
PQPubID | 35973 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1808622503 proquest_miscellaneous_1795867162 proquest_journals_2640630592 proquest_journals_1794490790 gale_infotracmisc_A456094735 gale_infotracacademiconefile_A456094735 gale_healthsolutions_A650057170 gale_healthsolutions_A456094735 pubmed_primary_26040439 crossref_citationtrail_10_1038_jhh_2015_59 crossref_primary_10_1038_jhh_2015_59 springer_journals_10_1038_jhh_2015_59 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-07-01 |
PublicationDateYYYYMMDD | 2016-07-01 |
PublicationDate_xml | – month: 07 year: 2016 text: 2016-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Journal of human hypertension |
PublicationTitleAbbrev | J Hum Hypertens |
PublicationTitleAlternate | J Hum Hypertens |
PublicationYear | 2016 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Niskanen, Laaksonen, Nyyssönen, Punnonen, Valkonen, Fuentes (CR24) 2004; 44 Ataoglu, Yilmaz, Uzunhasan, Cetin, Temiz, Döventaş (CR32) 2010; 38 Sinning, Sinning, Schulz, Schnabel, Lubos, Wild (CR9) 2011; 75 Miller, Xu, Asquith, Denby, Li, Sattar (CR34) 2008; 205 Yasunaga, Ikeda, Koga, Nakata, Yoshida, Masuda (CR6) 2014; 55 Mallamaci, Leonardis, Pizzini, Cutrupi, Tripepi, Zoccali (CR10) 2013; 31 Demyanets, Konya, Kastl, Kaun, Rauscher, Niessner (CR11) 2011; 31 Melander, Newton-Cheh, Almgren, Hedblad, Berglund, Engström (CR19) 2009; 302 Zhang, Wang, Wang, Tong, Zhang (CR18) 2013; 22 Savoia, Schiffrin (CR1) 2006; 15 Peer, Boaz, Zipora, Shargorodsky (CR25) 2013; 22 Ozdogan, Bozcuk, Coban (CR22) 2007; 13 Bautista, López-Jaramillo, Vera, Casas, Otero, Guaracao (CR21) 2001; 19 O'Brien, Waeber, Parati, Staessen, Myers (CR13) 2001; 322 O'Brien, Coats, Owens, Petrie, Padfield, Littler (CR14) 2000; 320 Ridker, Buring, Shih, Matias, Hennekens (CR5) 1998; 98 Dandona, Nix, Wilson, Aljada, Love, Assicot (CR8) 1994; 79 Pauletto, Rattazzi (CR16) 2006; 21 Büyükkaya, Karakaş, Kurt, Motor, Akçay, Büyükkaya (CR30) 2013; 41 Grossman (CR2) 2008; 31 Pickering, James, Boddie, Harshfield, Blank, Laragh (CR3) 1988; 259 Amer, Elawam, Khater, Omar, Mabrouk, Taha (CR27) 2011; 5 Lu, Guo, Hu, Wu, Zhou, Zhou (CR17) 2013; 47 Turak, Özcan, Canpolat, Işleyen, Cebeci, Öksüz (CR26) 2013; 18 Blake, Ridker (CR4) 2001; 89 Yano, Matsuda, Hatakeyama, Sato, Imamura, Shimada (CR31) 2010; 65 Gupta, Sachdeva, Khan, Haque (CR28) 2011; 22 Pignoli, Tremoli, Poli, Oreste, Paoletti (CR15) 1986; 74 Miller (CR12) 2011; 8 Sung, Suh, Kim, Kang, Kim, Lee (CR20) 2003; 16 Sesso, Buring, Rifai, Blake, Gaziano, Ridker (CR23) 2003; 290 Parlak, Aydoğan, Iyisoy, Dikililer, Kut, Cakır (CR29) 2012; 12 Bottazzi, Bastone, Doni, Garlanda, Valentino, Deban (CR7) 2006; 79 Choi, Choi, Min, Pyun, Maeng, Park (CR35) 2009; 114 Schiopu, Hedblad, Engström, Struck, Morgenthaler, Melander (CR33) 2012; 272 E O'Brien (BFjhh201559_CR13) 2001; 322 O Melander (BFjhh201559_CR19) 2009; 302 E O'Brien (BFjhh201559_CR14) 2000; 320 HD Sesso (BFjhh201559_CR23) 2003; 290 B Bottazzi (BFjhh201559_CR7) 2006; 79 P Pauletto (BFjhh201559_CR16) 2006; 21 CR Sinning (BFjhh201559_CR9) 2011; 75 L Niskanen (BFjhh201559_CR24) 2004; 44 Y Yano (BFjhh201559_CR31) 2010; 65 E Grossman (BFjhh201559_CR2) 2008; 31 V Gupta (BFjhh201559_CR28) 2011; 22 AM Miller (BFjhh201559_CR12) 2011; 8 LE Bautista (BFjhh201559_CR21) 2001; 19 TG Pickering (BFjhh201559_CR3) 1988; 259 PM Ridker (BFjhh201559_CR5) 1998; 98 AM Miller (BFjhh201559_CR34) 2008; 205 HH Lu (BFjhh201559_CR17) 2013; 47 P Dandona (BFjhh201559_CR8) 1994; 79 KC Sung (BFjhh201559_CR20) 2003; 16 A Parlak (BFjhh201559_CR29) 2012; 12 S Demyanets (BFjhh201559_CR11) 2011; 31 P Pignoli (BFjhh201559_CR15) 1986; 74 GJ Blake (BFjhh201559_CR4) 2001; 89 M Peer (BFjhh201559_CR25) 2013; 22 HE Ataoglu (BFjhh201559_CR32) 2010; 38 T Yasunaga (BFjhh201559_CR6) 2014; 55 M Zhang (BFjhh201559_CR18) 2013; 22 E Büyükkaya (BFjhh201559_CR30) 2013; 41 C Savoia (BFjhh201559_CR1) 2006; 15 O Turak (BFjhh201559_CR26) 2013; 18 YS Choi (BFjhh201559_CR35) 2009; 114 F Mallamaci (BFjhh201559_CR10) 2013; 31 MS Amer (BFjhh201559_CR27) 2011; 5 A Schiopu (BFjhh201559_CR33) 2012; 272 M Ozdogan (BFjhh201559_CR22) 2007; 13 19567439 - JAMA. 2009 Jul 1;302(1):49-57 16464884 - Nephrol Dial Transplant. 2006 Apr;21(4):850-3 24436616 - Int J Angiol. 2013 Dec;22(4):223-8 12799089 - Am J Hypertens. 2003 Jun;16(6):429-33 7989463 - J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8 22530956 - J Intern Med. 2012 Nov;272(5):484-91 23949417 - Blood Press Monit. 2013 Oct;18(5):259-64 18049438 - Med Sci Monit. 2007 Dec;13(12):CR570-3 15492131 - Hypertension. 2004 Dec;44(6):859-65 24507232 - Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Nov;47(11):1026-30 18268038 - J Exp Med. 2008 Feb 18;205(2):339-46 21524639 - J Am Soc Hypertens. 2011 Sep-Oct;5(5):395-400 16481882 - Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8 11393667 - J Hypertens. 2001 May;19(5):857-61 21871091 - J Inflamm (Lond). 2011 Aug 26;8(1):22 16478917 - J Leukoc Biol. 2006 May;79(5):909-12 11230071 - BMJ. 2001 Mar 3;322(7285):531-6 20233513 - J Int Med Res. 2010 Jan-Feb;38(1):52-61 21378450 - Circ J. 2011;75(5):1184-91 10775227 - BMJ. 2000 Apr 22;320(7242):1128-34 21196621 - Saudi J Kidney Dis Transpl. 2011 Jan;22(1):97-103 14665655 - JAMA. 2003 Dec 10;290(22):2945-51 3536154 - Circulation. 1986 Dec;74(6):1399-406 19661270 - Blood. 2009 Oct 1;114(14 ):3117-26 21737781 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9 23210729 - Blood Press. 2013 Jun;22(3):151-7 11679405 - Circ Res. 2001 Oct 26;89(9):763-71 3336140 - JAMA. 1988 Jan 8;259(2):225-8 20203097 - J Gerontol A Biol Sci Med Sci. 2010 May;65(5):547-52 23743803 - J Hypertens. 2013 Jul;31(7):1424-30; discussion 1430 9727541 - Circulation. 1998 Aug 25;98(8):731-3 23760115 - Turk Kardiyol Dern Ars. 2013 Jun;41(4):290-5 22466361 - Anadolu Kardiyol Derg. 2012 Jun;12(4):298-304 18227483 - Diabetes Care. 2008 Feb;31 Suppl 2:S185-9 24632958 - Int Heart J. 2014;55(2):160-4 |
References_xml | – volume: 15 start-page: 152 year: 2006 end-page: 158 ident: CR1 article-title: Inflammation in hypertension publication-title: Curr Opin Nephrol Hypertens – volume: 22 start-page: 151 year: 2013 end-page: 157 ident: CR18 article-title: Association of hypertension with coexistence of abnormal metabolism and inflammation and endothelial dysfunction publication-title: Blood Press doi: 10.3109/08037051.2012.745226 – volume: 41 start-page: 290 year: 2013 end-page: 295 ident: CR30 article-title: The serum pentraxin-3 is elevated in patients with cardiac syndrome X publication-title: Turk Kardiyol Dern Ars doi: 10.5543/tkda.2013.20025 – volume: 65 start-page: 547 year: 2010 end-page: 552 ident: CR31 article-title: Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glq030 – volume: 272 start-page: 484 year: 2012 end-page: 491 ident: CR33 article-title: Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study publication-title: J Intern Med doi: 10.1111/j.1365-2796.2012.02548.x – volume: 98 start-page: 731 year: 1998 end-page: 733 ident: CR5 article-title: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women publication-title: Circulation doi: 10.1161/01.CIR.98.8.731 – volume: 21 start-page: 850 year: 2006 end-page: 853 ident: CR16 article-title: Inflammation and hypertension: the search for a link publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfl019 – volume: 75 start-page: 1184 year: 2011 end-page: 1191 ident: CR9 article-title: AtheroGene Study Investigators. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease publication-title: Circ J doi: 10.1253/circj.CJ-10-0638 – volume: 18 start-page: 259 year: 2013 end-page: 264 ident: CR26 article-title: Increased echocardiographic epicardial fat thickness and high-sensitivity CRP level indicate diastolic dysfunction in patients with newly diagnosed essential hypertension publication-title: Blood Press Monit doi: 10.1097/MBP.0b013e3283651d19 – volume: 79 start-page: 1605 year: 1994 end-page: 1608 ident: CR8 article-title: Procalcitonin increase after endotoxin injection in normal subjects publication-title: J Clin Endocrinol Metab – volume: 12 start-page: 298 year: 2012 end-page: 304 ident: CR29 article-title: Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study publication-title: Anadolu Kardiyol Derg – volume: 79 start-page: 909 year: 2006 end-page: 912 ident: CR7 article-title: The long pentraxin PTX3 as a link among innate immunity, inflamatıon and female fertility publication-title: J Leukoc Biol doi: 10.1189/jlb.1005557 – volume: 31 start-page: 1424 year: 2013 end-page: 1430 ident: CR10 article-title: Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial publication-title: J Hypertens doi: 10.1097/HJH.0b013e328360ddd5 – volume: 322 start-page: 531 year: 2001 end-page: 536 ident: CR13 article-title: Blood pressure measuring devices: recommendations of the European Society of Hypertension publication-title: BMJ doi: 10.1136/bmj.322.7285.531 – volume: 22 start-page: 223 year: 2013 end-page: 228 ident: CR25 article-title: Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors publication-title: Int J Angiol doi: 10.1055/s-0033-1348880 – volume: 302 start-page: 49 year: 2009 end-page: 57 ident: CR19 article-title: Novel and conventional biomarkers for prediction of incident cardiovascular events in the community publication-title: JAMA doi: 10.1001/jama.2009.943 – volume: 114 start-page: 3117 year: 2009 end-page: 3126 ident: CR35 article-title: Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production publication-title: Blood doi: 10.1182/blood-2009-02-203372 – volume: 47 start-page: 1026 year: 2013 end-page: 1030 ident: CR17 article-title: The prospective study of association between C-reactive protein and hypertension in community population publication-title: Zhonghua Yu Fang Yi Xue Za Zhi – volume: 290 start-page: 2945 year: 2003 end-page: 2951 ident: CR23 article-title: C-reactive protein and the risk of developing hypertension publication-title: JAMA doi: 10.1001/jama.290.22.2945 – volume: 205 start-page: 339 year: 2008 end-page: 346 ident: CR34 article-title: IL-33 reduces the development of atherosclerosis publication-title: J Exp Med doi: 10.1084/jem.20071868 – volume: 13 start-page: CR570 year: 2007 end-page: CR573 ident: CR22 article-title: Low-grade inflammation in white-coat hypertension publication-title: Med Sci Monit – volume: 31 start-page: S185 year: 2008 end-page: S189 ident: CR2 article-title: Does increased oxidative stress cause hypertension? publication-title: Diabetes Care doi: 10.2337/dc08-s246 – volume: 5 start-page: 395 year: 2011 end-page: 400 ident: CR27 article-title: Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults publication-title: J Am Soc Hypertens doi: 10.1016/j.jash.2011.03.004 – volume: 38 start-page: 52 year: 2010 end-page: 61 ident: CR32 article-title: Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome publication-title: J Int Med Res doi: 10.1177/147323001003800106 – volume: 74 start-page: 1399 year: 1986 end-page: 1406 ident: CR15 article-title: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging publication-title: Circulation doi: 10.1161/01.CIR.74.6.1399 – volume: 44 start-page: 859 year: 2004 end-page: 865 ident: CR24 article-title: Inflammation, abdominal obesity, and smoking as predictors of hypertension publication-title: Hypertension doi: 10.1161/01.HYP.0000146691.51307.84 – volume: 8 start-page: 22 year: 2011 ident: CR12 article-title: Role of IL-33 in inflammation and disease publication-title: J Inflamm (Lond) doi: 10.1186/1476-9255-8-22 – volume: 55 start-page: 160 year: 2014 end-page: 164 ident: CR6 article-title: Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein publication-title: Int Heart J doi: 10.1536/ihj.13-253 – volume: 19 start-page: 857 year: 2001 end-page: 861 ident: CR21 article-title: Is C-reactive protein an independent risk factor for essential hypertension? publication-title: J Hypertens doi: 10.1097/00004872-200105000-00004 – volume: 31 start-page: 2080 year: 2011 end-page: 2089 ident: CR11 article-title: Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.231431 – volume: 16 start-page: 429 year: 2003 end-page: 433 ident: CR20 article-title: High sensitivity C-reactive protein as an independent risk factor for essential hypertension publication-title: Am J Hypertens doi: 10.1016/S0895-7061(03)00566-1 – volume: 89 start-page: 763 year: 2001 end-page: 771 ident: CR4 article-title: Novel clinical markers of vascular wall inflammation publication-title: Circ Res doi: 10.1161/hh2101.099270 – volume: 320 start-page: 1128 year: 2000 end-page: 1134 ident: CR14 article-title: Use and interpretation of Ambulatory blood pressure monitoring: recommendations of the British Hypertension Society publication-title: BMJ doi: 10.1136/bmj.320.7242.1128 – volume: 22 start-page: 97 year: 2011 end-page: 103 ident: CR28 article-title: Endothelial dysfunction and inflammation in different stages of essential hypertension publication-title: Saudi J Kidney Dis Transpl – volume: 259 start-page: 225 year: 1988 end-page: 228 ident: CR3 article-title: How common is white coat hypertension? publication-title: JAMA doi: 10.1001/jama.1988.03720020027031 – volume: 22 start-page: 151 year: 2013 ident: BFjhh201559_CR18 publication-title: Blood Press doi: 10.3109/08037051.2012.745226 – volume: 13 start-page: CR570 year: 2007 ident: BFjhh201559_CR22 publication-title: Med Sci Monit – volume: 55 start-page: 160 year: 2014 ident: BFjhh201559_CR6 publication-title: Int Heart J doi: 10.1536/ihj.13-253 – volume: 18 start-page: 259 year: 2013 ident: BFjhh201559_CR26 publication-title: Blood Press Monit doi: 10.1097/MBP.0b013e3283651d19 – volume: 89 start-page: 763 year: 2001 ident: BFjhh201559_CR4 publication-title: Circ Res doi: 10.1161/hh2101.099270 – volume: 31 start-page: S185 year: 2008 ident: BFjhh201559_CR2 publication-title: Diabetes Care doi: 10.2337/dc08-s246 – volume: 31 start-page: 2080 year: 2011 ident: BFjhh201559_CR11 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.231431 – volume: 302 start-page: 49 year: 2009 ident: BFjhh201559_CR19 publication-title: JAMA doi: 10.1001/jama.2009.943 – volume: 22 start-page: 223 year: 2013 ident: BFjhh201559_CR25 publication-title: Int J Angiol doi: 10.1055/s-0033-1348880 – volume: 15 start-page: 152 year: 2006 ident: BFjhh201559_CR1 publication-title: Curr Opin Nephrol Hypertens – volume: 22 start-page: 97 year: 2011 ident: BFjhh201559_CR28 publication-title: Saudi J Kidney Dis Transpl – volume: 8 start-page: 22 year: 2011 ident: BFjhh201559_CR12 publication-title: J Inflamm (Lond) doi: 10.1186/1476-9255-8-22 – volume: 38 start-page: 52 year: 2010 ident: BFjhh201559_CR32 publication-title: J Int Med Res doi: 10.1177/147323001003800106 – volume: 5 start-page: 395 year: 2011 ident: BFjhh201559_CR27 publication-title: J Am Soc Hypertens doi: 10.1016/j.jash.2011.03.004 – volume: 272 start-page: 484 year: 2012 ident: BFjhh201559_CR33 publication-title: J Intern Med doi: 10.1111/j.1365-2796.2012.02548.x – volume: 205 start-page: 339 year: 2008 ident: BFjhh201559_CR34 publication-title: J Exp Med doi: 10.1084/jem.20071868 – volume: 79 start-page: 909 year: 2006 ident: BFjhh201559_CR7 publication-title: J Leukoc Biol doi: 10.1189/jlb.1005557 – volume: 79 start-page: 1605 year: 1994 ident: BFjhh201559_CR8 publication-title: J Clin Endocrinol Metab – volume: 290 start-page: 2945 year: 2003 ident: BFjhh201559_CR23 publication-title: JAMA doi: 10.1001/jama.290.22.2945 – volume: 21 start-page: 850 year: 2006 ident: BFjhh201559_CR16 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfl019 – volume: 12 start-page: 298 year: 2012 ident: BFjhh201559_CR29 publication-title: Anadolu Kardiyol Derg – volume: 44 start-page: 859 year: 2004 ident: BFjhh201559_CR24 publication-title: Hypertension doi: 10.1161/01.HYP.0000146691.51307.84 – volume: 98 start-page: 731 year: 1998 ident: BFjhh201559_CR5 publication-title: Circulation doi: 10.1161/01.CIR.98.8.731 – volume: 322 start-page: 531 year: 2001 ident: BFjhh201559_CR13 publication-title: BMJ doi: 10.1136/bmj.322.7285.531 – volume: 320 start-page: 1128 year: 2000 ident: BFjhh201559_CR14 publication-title: BMJ doi: 10.1136/bmj.320.7242.1128 – volume: 31 start-page: 1424 year: 2013 ident: BFjhh201559_CR10 publication-title: J Hypertens doi: 10.1097/HJH.0b013e328360ddd5 – volume: 65 start-page: 547 year: 2010 ident: BFjhh201559_CR31 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glq030 – volume: 19 start-page: 857 year: 2001 ident: BFjhh201559_CR21 publication-title: J Hypertens doi: 10.1097/00004872-200105000-00004 – volume: 41 start-page: 290 year: 2013 ident: BFjhh201559_CR30 publication-title: Turk Kardiyol Dern Ars doi: 10.5543/tkda.2013.20025 – volume: 259 start-page: 225 year: 1988 ident: BFjhh201559_CR3 publication-title: JAMA doi: 10.1001/jama.1988.03720020027031 – volume: 114 start-page: 3117 year: 2009 ident: BFjhh201559_CR35 publication-title: Blood doi: 10.1182/blood-2009-02-203372 – volume: 47 start-page: 1026 year: 2013 ident: BFjhh201559_CR17 publication-title: Zhonghua Yu Fang Yi Xue Za Zhi – volume: 16 start-page: 429 year: 2003 ident: BFjhh201559_CR20 publication-title: Am J Hypertens doi: 10.1016/S0895-7061(03)00566-1 – volume: 75 start-page: 1184 year: 2011 ident: BFjhh201559_CR9 publication-title: Circ J doi: 10.1253/circj.CJ-10-0638 – volume: 74 start-page: 1399 year: 1986 ident: BFjhh201559_CR15 publication-title: Circulation doi: 10.1161/01.CIR.74.6.1399 – reference: 12799089 - Am J Hypertens. 2003 Jun;16(6):429-33 – reference: 23949417 - Blood Press Monit. 2013 Oct;18(5):259-64 – reference: 20233513 - J Int Med Res. 2010 Jan-Feb;38(1):52-61 – reference: 21378450 - Circ J. 2011;75(5):1184-91 – reference: 21871091 - J Inflamm (Lond). 2011 Aug 26;8(1):22 – reference: 21196621 - Saudi J Kidney Dis Transpl. 2011 Jan;22(1):97-103 – reference: 16464884 - Nephrol Dial Transplant. 2006 Apr;21(4):850-3 – reference: 21737781 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9 – reference: 22530956 - J Intern Med. 2012 Nov;272(5):484-91 – reference: 3536154 - Circulation. 1986 Dec;74(6):1399-406 – reference: 11679405 - Circ Res. 2001 Oct 26;89(9):763-71 – reference: 18049438 - Med Sci Monit. 2007 Dec;13(12):CR570-3 – reference: 11393667 - J Hypertens. 2001 May;19(5):857-61 – reference: 10775227 - BMJ. 2000 Apr 22;320(7242):1128-34 – reference: 18227483 - Diabetes Care. 2008 Feb;31 Suppl 2:S185-9 – reference: 7989463 - J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8 – reference: 11230071 - BMJ. 2001 Mar 3;322(7285):531-6 – reference: 16481882 - Curr Opin Nephrol Hypertens. 2006 Mar;15(2):152-8 – reference: 24632958 - Int Heart J. 2014;55(2):160-4 – reference: 14665655 - JAMA. 2003 Dec 10;290(22):2945-51 – reference: 3336140 - JAMA. 1988 Jan 8;259(2):225-8 – reference: 18268038 - J Exp Med. 2008 Feb 18;205(2):339-46 – reference: 19567439 - JAMA. 2009 Jul 1;302(1):49-57 – reference: 23210729 - Blood Press. 2013 Jun;22(3):151-7 – reference: 23743803 - J Hypertens. 2013 Jul;31(7):1424-30; discussion 1430 – reference: 21524639 - J Am Soc Hypertens. 2011 Sep-Oct;5(5):395-400 – reference: 24507232 - Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Nov;47(11):1026-30 – reference: 22466361 - Anadolu Kardiyol Derg. 2012 Jun;12(4):298-304 – reference: 20203097 - J Gerontol A Biol Sci Med Sci. 2010 May;65(5):547-52 – reference: 23760115 - Turk Kardiyol Dern Ars. 2013 Jun;41(4):290-5 – reference: 19661270 - Blood. 2009 Oct 1;114(14 ):3117-26 – reference: 16478917 - J Leukoc Biol. 2006 May;79(5):909-12 – reference: 15492131 - Hypertension. 2004 Dec;44(6):859-65 – reference: 24436616 - Int J Angiol. 2013 Dec;22(4):223-8 – reference: 9727541 - Circulation. 1998 Aug 25;98(8):731-3 |
SSID | ssj0014768 |
Score | 2.2013988 |
Snippet | An association has been described between inflammation and the progression of hypertension (HT) and is shown with several biochemical parameters. Our aim was... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 424 |
SubjectTerms | 692/699/75/243 Adult Arteriosclerosis Biological markers Biomarkers Biomarkers - blood Blood Pressure C-reactive protein C-Reactive Protein - analysis Calcitonin Calcitonin - blood Cardiovascular diseases Cardiovascular research Carotid Intima-Media Thickness Case-Control Studies Comparative analysis Diagnosis Epidemiology Female Health Administration Health aspects Humans Hypertension Inflammation Inflammation - blood Inflammation - diagnosis Inflammation - physiopathology Inflammation Mediators - blood Interleukin-33 - blood Male Medicine Medicine & Public Health Middle Aged original-article Pattern recognition receptors Pentraxins Procalcitonin Public Health Risk factors Serum Amyloid P-Component - analysis Up-Regulation White Coat Hypertension - blood White Coat Hypertension - diagnosis White Coat Hypertension - physiopathology |
Title | Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension |
URI | https://link.springer.com/article/10.1038/jhh.2015.59 https://www.ncbi.nlm.nih.gov/pubmed/26040439 https://www.proquest.com/docview/1794490790 https://www.proquest.com/docview/2640630592 https://www.proquest.com/docview/1795867162 https://www.proquest.com/docview/1808622503 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS9xAEB_qCaUvpd_GWpuCpVDYmmR3k11fxBZFCoqUCvdQCNmPoEUSvTtp_3xnkr14Z61PIezcsjeZmf3NzscCbBmDm6TjlqVWJgzxv2PKK8OcUHVecKG5oGrko-P88FR8H8txOHCbhrTKuU3sDLVrLZ2Rb-PGTe2hpM52L68Y3RpF0dVwhcYKrKIJVnIEq1_3j09-DHEEUXTFcIgjEoaeRhIq9BKutn-fUSwilV-oTenCnnTXMi9sTXdipd0WdPAMngbsGO_1H_s5PPLNC3h8FKLjL-EXZf1XFxaVtDlv4qpx8Ul3ePv3vGF8Jw69mGIquaesnMk0RjIUMZSKvoKR3v9QYCG2bTWLz9BJnXQp7m3zCk4P9n9-O2Th9gRmpRAzJnStlNXOZLVDNxcfwmSFdxK1WqM_XXNpuasznxlXqVonWqXc5DbxhPmM5a9h1LSNX4MYIQx6OqISOjUC_UclUl-lXppE4499FsHnOf9KG1qL0w0XF2UX4uaqRGaXxOxS6gi2BuLLvqPG_WTv6UOUfTnooIflHiI-dEkLLv9LgaATUWhaJBF86ihIV3E9tgolB_ivqOvV0lwbS5SoY3Z5eC4OZdDxaUmmTGhkZnLv8K3ARvBhGKaJKa2t8e11N4WkBoP5QzSKvE5EqjyCN70kDnxDZ5S6IyGzPs5Fc2F9_zJ1_eGFvoUnSJj32cgbMJpNrv07xFwzswkrxbjYDOp1A45gKW8 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3ra9RAEF9qC-oX8W202ggtgrA2ye4mu4JI1Zar7R1FWugHYc0-QislqXdXqv-Uf6MzeXlXa7_1Uwg7WTaTefwmszNLyKox4CQdszS2IqKA_x2VXhrquCzSjHHFOFYjD0fp4IB_PhSHC-R3VwuD2yo7m1gbaldZ_Ee-Do4b20MJlbw__UHx1CjMrnZHaDRiseN_nUPINnm3_Qm-71qSbG3ufxzQ9lQBagXnU8pVIaVVziSFg_APLtwkmXcCpF1BnFkwYZkrEp8Yl8tCRUrGzKQ28oiFjGUw7w2yBDBDgRYtfdgc7X3p8xY8q4vvALdEFCKbqK0IjJhc_36EuY9YvMG2qDM-8KInmHGFF3KztcvbukvutFg13GiE6x5Z8OV9cnPYZuMfkK9YZZCfWDAK5XEZ5qUL9-qfxT-PS8rehm3vpxBL_HEX0HgSAhmINEhhUzGJ9-eYyAhtlU_DIwiKx_WW-qp8SA6uha-PyGJZlf4JCQEyQWTFc65iwyFelTz2eeyFiRQ87JOAvO74p23byhxP1DjRdUqdSQ3M1shsLVRAVnvi06aDx-VkK_ghdFN-2uu93gCECSFwxsR_KQDkAuqNsyggr2oKtA2wHpu3JQ7wVthla26u5TlK0Gk7P9yJg25tykSj6eQKmBldOvxXQQLysh_GiXEbXemrs3oKgQ0N06toJEa5gIxZQB43ktjzDYJf7MYEzFrrRHNmff8y9enVC10htwb7w129uz3aeUZuw0NpsxN6mSxOx2f-OeC9qXnRKllIvl23Xv8B3I9miQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB_qFYov4rfRaiO0CEK8JLt72RVEqu3RWnscYqEPhZjdbGilJPXuSvVf869zJtnEu1r71qcQdrJsJrMz88t8LMC61mgkc2aCyIgwQP8_D6SVOsi5LAYJ44pxqkbeHw12DvinQ3G4BL_bWhhKq2x1Yq2o88rQP_I-Gm5qDyVU3C9cWsR4a_j-7EdAJ0hRpLU9TqMRkT376wLh2_Td7hZ-6404Hm5__bgTuBMGAiM4nwVcFVIaleu4yBEK4oXrOLG5QMlXiDkLJgzLi9jGOs9koUIlI6YHJrTkF2nDcN5bsJzg0mQPlj9sj8ZfuhgGT-pCPPRhwgBRTuiqA0Mm-9-PKQ4SiTfUInXOHl62CnNm8VKctjZ_w7twx_mt_mYjaPdgyZb3YWXfReYfwBFVHGSnBhVEeVL6WZn74_rH8c-TMmBvfdcHyqdyf8oImkx9JEPxRolsqifp_oKCGr6pspl_jAB5UqfXV-VDOLgRvj6CXlmV9gn46D4hyuIZV5HmiF0lj2wWWaFDhQ_b2IPXLf9S49qa0-kap2kdXmcyRWanxOxUKA_WO-KzppvH1WRr9CHSphS10wHpJnqbCIcTJv5LgQ4vesBREnrwqqYgPYHrMZkrd8C3oo5bC3OtLlDi_jaLw604pE6_TFNSo1whM8Mrh_9uFg9edsM0MaXUlbY6r6cQ1NxwcB2NJMSLXjLz4HEjiR3fEAhTZyZk1kYrmnPr-5epT69f6Bqs4H5OP--O9p7BbXxm0CRFr0JvNjm3z9H1m-kXbo_58O2mt_UfjvVqtQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Procalcitonin+and+Pentraxin-3%3A+Current+biomarkers+in+inflammation+in+white+coat+hypertension&rft.jtitle=Journal+of+human+hypertension&rft.au=Yavuzer%2C+H&rft.au=Cengiz%2C+M&rft.au=Yavuzer%2C+S&rft.au=R%C4%B1za+Alt%C4%B1parmak%2C+M&rft.date=2016-07-01&rft.eissn=1476-5527&rft.volume=30&rft.issue=7&rft.spage=424&rft_id=info:doi/10.1038%2Fjhh.2015.59&rft_id=info%3Apmid%2F26040439&rft.externalDocID=26040439 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9240&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9240&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9240&client=summon |